Group One Trading
CUE icon

Group One Trading’s Cue Biopharma CUE Stock Holding History

Group One Trading’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-133
Closed -$3.64K – 8029
2025
Q1 		$3.64K Sell
133
-67
-34% -$2.49K ﹤0.01% 6776
2024
Q4 		$6.54K Hold
200
– – ﹤0.01% 6304
2024
Q3 		$4.54K Buy
200
+137
+217% +$2.97K ﹤0.01% 5912
2024
Q2 		$2.36K Buy
63
+13
+26% +$643 ﹤0.01% 6178
2024
Q1 		$2.83K Sell
50
-333
-87% -$23.5K ﹤0.01% 6398
2023
Q4 		$30.4K Sell
383
-10
-3% -$715 ﹤0.01% 5430
2023
Q3 		$27.1K Sell
393
-4
-1% -$391 ﹤0.01% 5638
2023
Q2 		$43.4K Hold
397
– – ﹤0.01% 5389
2023
Q1 		$42.5K Buy
397
+4
+1% +$382 ﹤0.01% 4973
2022
Q4 		$33.6K Buy
393
+93
+31% +$8.51K ﹤0.01% 5264
2022
Q3 		$20K Sell
300
-773
-72% -$66.5K ﹤0.01% 6065
2022
Q2 		$80K Buy
1,073
+60
+6% +$7.02K ﹤0.01% 5183
2022
Q1 		$148K Buy
1,013
+296
+41% +$62.8K ﹤0.01% 5107
2021
Q4 		$243K Buy
717
+714
+23,800% +$276K ﹤0.01% 4900
2021
Q3 		$1K Buy
+3
New +$1.05K ﹤0.01% 8010

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
GWMR
GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Group One Trading's CUE Position: Q2 2025 in Review

Group One Trading sold out of Cue Biopharma (CUE) in Q2 2025, closing a stake of 452 shares — an estimated $12.4K sold.

Group One Trading first reported a position in CUE in Q2 2021 and held it in 7 quarters. The position peaked at $36K in Q2 2022. 47 funds tracked by Wall St. Rank hold CUE as of Q2 2025.

  • Group One Trading reported no remaining Cue Biopharma position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 452 Cue Biopharma shares in Q2 2025, an estimated $12.4K.
  • Group One Trading first reported a position in Cue Biopharma in Q2 2021 and held it in 7 quarters.
  • Group One Trading's Cue Biopharma position peaked at $36K in Q2 2022.
  • 47 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.